Wednesday, October 31, 2007

Postdischarge low molecular weight heparin for VTE prophylaxis

This is a common practice for surgical patients, but the experience in high risk medical patients has been limited. Now there’s evidence to support it from a randomized trial. Results were recently presented at the 21st Congress of the International Society on Thrombosis and Hemostasis.

Via Medscape.

No comments: